XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Total revenues $ 37,428 $ 42,046 $ 113,683 $ 138,427
Cost of goods sold        
Cost of product and other revenue 5,150 8,998 15,780 28,452
Amortization of intangible asset 9,011 9,011 27,032 27,032
Total cost of goods sold 14,161 18,009 42,812 55,484
Operating expenses:        
Research and development 8,487 13,330 25,866 53,214
Selling, general and administrative 26,516 22,710 78,870 74,797
License 769 864 2,242 2,381
Restructuring 0 169 58 181
Total operating expenses 35,772 37,073 107,036 130,573
Loss from operations (12,505) (13,036) (36,165) (47,630)
Other income (expense)        
Interest expense (6,661) (1,410) (11,308) (4,614)
Other (expense) income (17) (43) 39 229
Change in fair value of warrant liability (856) 0 1,345 0
Loss on extinguishment of debt 0 0 (517) 0
Loss on termination of lease 0 0 0 (524)
Net loss before income taxes (20,039) (14,489) (46,606) (52,539)
Net loss, basic (20,039) (14,489) (46,606) (52,539)
Net loss, diluted (20,039) (14,489) (46,606) (52,539)
Comprehensive loss $ (20,039) $ (14,489) $ (46,606) $ (52,539)
Net loss per share:        
Basic (in dollars per share) $ (0.10) $ (0.08) $ (0.22) $ (0.28)
Diluted (in dollars per share) $ (0.10) $ (0.08) $ (0.22) $ (0.28)
Weighted average common shares outstanding:        
Basic (in shares) 210,348,459 188,306,350 208,343,679 186,643,878
Diluted (in shares) 210,348,459 188,306,350 208,343,679 186,643,878
Product revenue, net        
Revenues        
Total revenues $ 35,592 $ 40,118 $ 107,810 $ 117,068
License, collaboration and other revenue        
Revenues        
Total revenues $ 1,836 $ 1,928 $ 5,873 $ 21,359